Issue link: https://www.e-digitaleditions.com/i/1532595
Bio/Pharma Outsourcing Innovation February 2025 BioPharm International ® | Pharmaceutical Technology ® 27 INDUSTRY TRENDS With this list summarizing only a fraction of the col- laborations that have progressed in just mere weeks' time so far in 2025, there will be plenty to watch for in the months ahead. References 1. DelveInsight. Contract Development Manufactur- ing Organizat ion (CDMO) –Market Insights , Com- p e t it i ve L an d s cap e an d M ark e t F o r e ca s t– 20 3 0; DelveInsight, 2023. 2. DelveInsight. Optimizing Outsourcing: A Case Study on Evaluating CDMO Capabilities for API and FD Development. Press Release. Jan. 2, 2025. 3. Biswas, S.; Bigelow, P.; Kane, A.; et al. CPHI Online Trend Report– Global CDMO Trends: T he 2024 Out- sourcing Forecast; CPHI Online, 2024. 4. Haigney, S. Sustainability in Pharmaceutical Out- sourcing. PharmTech.com, Jan. 29, 2025. 5. Bora Pharmaceuticals. Bora Biologics Announces Strategic Col laboration to Accelerate Key CMC Development of DotBio's Tri-Specific Antibody to Treat Cancer. Press Release. Jan. 9, 2025. 6. Phillips Medisize. Phillips Medisize Expands Its In- halation Drug Delivery Capabilities. Press Release. Jan. 7, 2025. 7. Samsung Biologics. Samsung Biologics Signs Man- ufacturing Deal with Europe-based Pharma. Fact Sheet. Jan. 13, 2025. 8. Scribe Therapeutics. Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi. Press Release. Jan. 13, 2025. 9. Hikma Pharmaceuticals. Hikma Announces Ex- clusive Commercial Partnership with Emergent BioSolutions for Kloxxado (naloxone HCl) Nasal Spray 8 mg. Press Release. Jan. 14, 2025. 10. Ly ndra T herapeutics. Ly ndra T herapeutics An- nounces Strategic Clinical Research and Commer- cial Manufacturing Ser vices Collaboration with T her mo Fisher Scient if ic for Long-Act ing Ora l Therapies. Press Release. Jan. 15, 2025. 11. Lantheus. Lantheus to Acquire Evergreen Ther- agnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Ful ly Integrated Radiopharmaceutical Leader. Press Release. Jan. 28, 2025. 12. Rentschler Biopharma. Rentschler Biopharma An- nounces Strategic Realignment of its Global Busi- ness Operations. Press Release. Jan. 30, 2025. 13. A rdena. A rdena Completes Acqu isit ion of Ad- vanced Drug Product Manufacturing Facility from Catalent and Expands Bioanaly tical Ser vices in North America. Press Release. Feb. 4, 2025. 14. Jabil. Jabil Acquires Pharmaceutics International, Inc. Press Release. Feb. 4, 2025. Highlighting the Benefits of Integrated Services When outsourced services are required, bio/phar- maceutical companies can take a more traditional approach, whereby they split their program up and use one or more contract development and man- ufacturing organizations (CDMOs) in addition to a separate contract research organization (CRO), or they can choose an integrated model. "[The term] 'integrated services' has multiple meanings," Kevin Li, MBA, chief marketing officer at BioDuro-Sundia, said in an interview with Pharmaceutical Technology Europe™ at CPHI Milan in October 2024. Integrated services can be viewed as horizontal, in that a partner would provide services covering discovery to development and commercial manufacturing, Li notes. If you then look vertically, it is possible to also integrate the medicinal chemistry, biology, and drug metabolism and pharmacokinetics into the discover y phase and through d e ve l o p m e n t , h e a d d s . " O n e side can handle both drug substance and drug product, and one side can handle the pre-formulation, formulation development, until commercial manufacturing, everything in one side," Li says, "so that integrated solution can really help customers to accelerate their innovation through multiple benefits." Benefits of using an integrated solution include the convenience of material transfer among different teams, the information sharing, and the quality system, which can help to speed up the program timescale, Li explains. "One of the biggest benefits is [that it is] very simple to manage the vendors , because it 's ver y dif ficult and time consuming to manage multiple vendors, and if you do integrate the program with one vendor through our integrated or dedicated project manager, that's much easier, simpler to manage the process to avoid any potential interruptions." Watch the full interview with Li at: https://www.pharmtech.com/view/cphi-milan-2024-high- lighting-the-benefits-of-integrated-services —Felicity Thomas